Area of research
Molecular Biology · Cancer Research
Research interest
Research focused on Cancer research and PLK1, with related work in EZH2, Triple-negative breast cancer, Protein tyrosine phosphatase. Notable publications include 'PDK1 Signaling Toward PLK1–MYC Activation Confers Oncogenic Transformation, Tumor-Initiating Cell Activation, and Resistance to mTOR-Targeted Therapy', 'EZH2-Mediated Inactivation of IFN-γ-JAK-STAT1 Signaling Is an Effective Therapeutic Target in MYC-Driven Prostate Cancer', and 'Protein tyrosine phosphatase UBASH3B is overexpressed in triple-negative breast cancer and promotes invasion and metastasis'.
EZH2-Mediated Inactivation of IFN-γ-JAK-STAT1 Signaling Is an Effective Therapeutic Target in MYC-Driven Prostate Cancer
PDK1 Signaling Toward PLK1–MYC Activation Confers Oncogenic Transformation, Tumor-Initiating Cell Activation, and Resistance to mTOR-Targeted Therapy
Protein tyrosine phosphatase <i>UBASH3B</i> is overexpressed in triple-negative breast cancer and promotes invasion and metastasis